Cancer before 50: Why causes matter more than quick answers
For some types of cancer, diagnoses before the age of 50 are rising. Research clues matter, but they replace neither a cause nor a new screening rule for Switzerland.
The rise in certain cancers among people under 50 occupies researchers worldwide. It does not, however, hand out a free pass for alarmist readings. What matters is to distinguish precisely: which cancers are increasing, and where? How much of that is explained by better diagnostics and changed registers? And which risks can actually be influenced?
A trend, but not a single disease
«Early cancer» bundles very different diagnoses. The increase in colorectal cancer before the age of 50 is particularly well documented in several wealthy countries. The International Agency for Research on Cancer (IARC) describes a pronounced cohort effect: higher rates appear in generations born from roughly 1955 to 1960. Other cancers may follow other trends. It follows that a single explanation for all young cancer patients would be unsound.
For early colorectal cancer, IARC researchers examined genetic and modifiable risk factors. Higher body weight, higher alcohol consumption and metabolic parameters such as elevated fasting insulin levels were associated with a higher risk in the analyses. These are indications of links and starting points for prevention, not a complete list of causes. The microbiome and influences from early phases of life are also being studied.
What follows from this for Switzerland
For Switzerland, the trend is a mandate for registries, family doctor practices and public information. The National Cancer Registry and the cantonal registries help to place changes in time and region. Without good data it remains unclear whether more cases point to a higher risk, to better recording, or to both.
For individuals, the finding does not mean that every abdominal complaint is a sign of cancer. Persistent bleeding, unexplained weight loss, marked changes in bowel habits or a strong family history should, however, be assessed by a doctor. Precisely because colorectal cancer is less expected in younger people, symptoms can be classified too late. This statement is not a call for self-diagnosis, but an argument for taking the route to assessment by a family doctor seriously.
Screening needs evidence, not fear
Swiss recommendations for early detection are guided by age, risk and the weighing of benefits and harms. General screening for everyone under 50 would only make sense if the benefit outweighed the effort, false alarms and overdiagnosis. The observed trend does not yet answer this question. It can, however, be a reason to review programmes regularly against new data and to advise people with an increased family risk in a targeted way.
Research must therefore not slip into a convenient narrative. Eating habits, excess weight, alcohol and physical activity are modifiable, but they do not explain every case. Genetic predisposition, chronic bowel diseases and chance also play a role. Anyone who describes risks in a differentiated way relieves those affected of blame and at the same time strengthens effective prevention.
The rise in early cancers is not proof of a single new danger. It is a signal that prevention and early detection must become more precise. For Switzerland, this means: robust cancer registries, good counselling and a medicine that does not dismiss symptoms with a reference to young age.
Sources
- IARC: Causes of the Global Increase in Early-Onset Colorectal Cancer
- IARC: Genetic and modifiable risk factors in early colorectal cancer
- National Cancer Registry: Cancer registration in Switzerland
